info icon

This is a non-core endpoint: only basic statistics are computed.

Mucopolysaccharidosis, other/unspecified

E4_MUCOPOLYNAS

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 E76.2, E76.3
  • Hospital discharge: ICD-9 2775
  • Cause of death: ICD-10 E76.2, E76.3
  • Cause of death: ICD-9 2775

2 out of 7 registries used, show all original rules.

6

4. Check minimum number of events

None

6

5. Include endpoints

None

6

6. Filter based on genotype QC (FinnGen only)

6

Control definitions (FinnGen only)

Control exclude
E4_METABOLIA

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2

Case counts by codes

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 184 91 91
Only index persons 117 56 61
Unadjusted period prevalence (%)
Whole population 0.00 0.00 0.00
Only index persons 0.00 0.00 0.00
Median age at first event (years)
Whole population 11.54 11.99 9.93
Only index persons 8.66 9.41 7.97

-FinnGen-

Key figures

All Female Male
Number of individuals 6 - -
Unadjusted period prevalence (%) 0.00 - -
Median age at first event (years) 12.40 - -

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
6
16
+∞
3.09
6.0
3.7
—
—
—
0
0
(3044889) 12 lead EKG panel
6
24
+∞
2.18
5.8
2.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
6
41
+∞
0.77
16.8
10.9
mg/l
16.1
19.9
—
6
30
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
0
18
0.00
0.75
0.0
2.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
0
17
0.00
0.49
0.0
1.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
6
49
+∞
0.24
21.5
6.7
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
6
50
+∞
0.24
27.0
9.5
umol/l
65.3
73.4
—
6
50
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
0
10
0.00
0.24
0.0
1.3
—
1.2
—
0
5
(3017143) Hepatitis C virus Ab [Presence] in Serum
0
10
0.00
0.24
0.0
1.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
0
9
0.00
0.23
0.0
3.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
0
13
0.00
0.23
0.0
1.5
—
—
—
0
0
(3000492) Spirometry study
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
10.1
—
0
7
(3004716) Salmonella sp identified in Stool by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
1.0
—
0
5
(3050129) First trimester maternal screen panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(1002224) Polysomnography panel
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
20.0
—
0
5
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
0
7
0.00
0.00
0.0
3.9
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
1.3
—
0
7

Mortality – FinRegistry

Association

Association between endpoint E4_MUCOPOLYNAS and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have E4_MUCOPOLYNAS.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

Index endpoint: E4_MUCOPOLYNAS – Mucopolysaccharidosis, other/unspecified

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data